BFLY - Butterfly Network, Inc.
NYSE
->
Healthcare
->
Medical Devices
Guilford,
United States
Type: Equity
BFLY price evolution
BFLY
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $16.11 | $13.91 | $13.42 | $13.6 |
| Inventory | $74.17 | $74.49 | $73.02 | $94 |
| Total current assets | $204.48 | $213.27 | $231.26 | $268.6 |
| Long term investments | ||||
| Property, plant & equipment | $37.94 | $39.75 | $41 | $42.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $273.07 | $284.29 | $304.27 | $334.2 |
| Current liabilities | ||||
| Accounts payable | $4.51 | $5.81 | $5.09 | $8.1 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $40.78 | $41.54 | $44.27 | $45.4 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $78.79 | $80.28 | $84.22 | $76.8 |
| Shareholders' equity | ||||
| Retained earnings | -$767.11 | -$751.4 | -$729.64 | -$685.5 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.16 | |||
| Short term investments | ||||
| Net receivables | $13.42 | $14.69 | $11.94 | |
| Inventory | $73.02 | $59.97 | $36.24 | |
| Total current assets | $231.26 | $357.14 | $511.9 | $0.32 |
| Long term investments | ||||
| Property, plant & equipment | $41 | $52.9 | $38.79 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $414.33 | |||
| Total investments | ||||
| Total assets | $304.27 | $417.57 | $571.97 | $414.65 |
| Current liabilities | ||||
| Accounts payable | $5.09 | $7.21 | $5.8 | $2.79 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $44.27 | $51.33 | $49.83 | $2.8 |
| Long term debt | ||||
| Total noncurrent liabilities | $406.85 | |||
| Total debt | ||||
| Total liabilities | $84.22 | $92.21 | $124.27 | $409.65 |
| Shareholders' equity | ||||
| Retained earnings | -$729.64 | -$595.94 | -$427.21 | -$132.2 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $19.21 | |||
| Cost of revenue | ||||
| Gross Profit | $10.57 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $59.03 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.02 | |||
| Interest expense | $13.06 | |||
| Net income | ||||
| Net income | -$35.8 | |||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 31 Jan 2020 | 30 Jan 2013 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $62.56 | $93.44 | ||
| Cost of revenue | ||||
| Gross Profit | $17.05 | $16.12 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $209.78 | $3.77 | $40.17 | |
| Operating income | -$3.77 | -$23.73 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.12 | $0.04 | ||
| Interest expense | $163.02 | $1.18 | ||
| Net income | ||||
| Net income | -$32.41 | -$132.2 | -$24.78 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$91.3 | -$11.58 | -$4.51 | -$9.87 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $2.74 | $0.71 | $0.55 | $565.69 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$228.81 | -$109.1 | -$58.19 | $366.63 |
| (in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2013 | 30 Jan 2012 |
|---|---|---|---|---|
| Net income | -$132.2 | -$24.91 | -$11.43 | |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$1.17 | -$3.01 | -$8.07 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$9.87 | -$413.98 | -$3.23 | -$4.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $565.69 | $415.3 | $3.12 | $6.88 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $366.63 | $0.16 | -$3.13 | -$6.02 |
News
Fundamentals
| Market cap | $359.07M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 212.46M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.01 |
| Quick ratio | 3.20 |